Key facts
- It has raised $1.0M across 1 recorded rounds; the latest was Seed Round ($1.0M) in Jun 2025.
- Elevate Clinical Research has filed 1 Form D with the SEC, most recently Feb 2026 ($1.0M sold to 7 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Elevate Clinical Research
Funding rounds
1 roundsAbout Elevate Clinical Research
Provider of clinical research services intended to conduct patient centered medical studies in collaboration with local healthcare professionals. The company partners with patients, physicians, and other healthcare stakeholders to design and manage clinical research protocols, enabling professionals to facilitate the generation of medical evidence and support improved patient outcomes.
- Sector
- Healthcare
- HQ
- Houston, TX, United States
- Founded
- 2024
- Employees
- 10
- Website
- elevateclinical.com/
- Ownership
- Privately Held (backing)
Elevate Clinical Research doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Elevate Clinical Research shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Elevate Clinical Research in its N-PORT filings yet. We sweep new filings monthly.